Tag: atrial fibrillation

In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Risk of Substantial Intraocular Bleeding With Novel Oral Anticoagulants The novel oral anticoagulants (NOAC) are an emerging hot topic in medicine given their cost-effectiveness and monitoring preference compared to the traditional vitamin...

1. This study compared three different methods of catheter ablation to manage persistent atrial fibrillation: pulmonary-vein isolation alone, isolation with ablation of complex fractionated electrograms, and isolation with linear ablation. 2. There were no significant differences between the three groups in the rates of freedom from atrial fibrillation episodes after...

1. In this systematic review, the off-label use of the Lariat device for left atrial appendage exclusion in patients with atrial fibrillation was associated with roughly 90% procedural success. 2. Out of 309 patients studied, there were 35 unique adverse events identified, including pericardial effusion, death, and need for urgent...

In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Long-Term Efficacy of a Hepatitis E Vaccine Hepatitis E virus (HEV) is most frequently a waterborne infection in resource-limited countries that can result in acute hepatitis and death especially in pregnant women....

Originally published by Harvard Health. What Is It? Atrial fibrillation is a heart rhythm disorder that causes a rapid and irregular heartbeat. Atrial fibrillation affects the upper two chambers of the heart, the atria. All blood circulates through both atria. The heart is a muscle. The walls of the chambers of the heart...

1. An atrial fibrillation-specific intervention program consisting of a home visit, Holter monitoring after hospital discharge, and prolonged follow-up was associated with a greater proportion of days alive and out of hospital, compared to standard intervention of routine primary care and outpatient follow-up 2. Atrial fibrillation-specific interventions did not significantly...

1. In patients with atrial fibrillation, the use of non-steroidal anti-inflammatory along with antithrombotic therapy (i.e., antiplatelets or anticoagulants) was associated with increased bleeding and thromboembolic events. Evidence Rating Level: 2 (Good) Study Rundown: Atrial fibrillation (AF) is an arrhythmia that markedly increases the risk for thromboembolic stroke. To mitigate this...

1. Patients with non-valvular atrial fibrillation who were receiving dabigatran for prevention of stroke and systemic embolism had a higher risk of major bleeding complications when compared with patients taking warfarin. The risk for intracranial hemorrhage, however, was lower, especially amongst older adults. 2. The study also identified several groups...

1. According to this systematic review, atrial fibrillation was linked to increased odds of silent cerebral infarctions, which are risk factors for future symptomatic strokes and dementia. Evidence Rating Level: 1 (Excellent) Study Rundown: Atrial fibrillation (AF) affects nearly three million Americans and is known to predispose patients to strokes. However,...

1. Beta-blocker therapy did not significantly reduce all-cause mortality or time-to-first cardiovascular hospital admission in patients with heart failure and atrial fibrillation, compared to placebo. 2. However, beta-blockers significantly reduced the all-cause mortality and time-to-first cardiovascular hospital admission in patients with heart failure and normal sinus rhythm, compared to...